Unlock instant, AI-driven research and patent intelligence for your innovation.

Preparation method of isavuconazonium sulfate and intermediate thereof

A technology of isavuconazole sulfate and chloroethyl chloroformate, applied in the field of drug synthesis, can solve the problems of low purity of final product, cumbersome process, time-consuming and labor-intensive, etc.

Active Publication Date: 2019-12-10
重庆世森医药科技有限公司
View PDF7 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

[0009] In addition, when the existing process prepares the final product of isavuconazole sulfate, for example, when the above-mentioned compound A4-1 is deprotected and ion-exchanged to obtain the final product, freeze-drying is usually required, the process is tedious, time-consuming and labor-intensive, and finally Product purity is not high
[0010] In summary, there are multiple problems in the existing preparation method of isavuconazole sulfate, in order to improve its production efficiency, yield and purity of the final product, it is necessary to improve its preparation method

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • Preparation method of isavuconazonium sulfate and intermediate thereof
  • Preparation method of isavuconazonium sulfate and intermediate thereof
  • Preparation method of isavuconazonium sulfate and intermediate thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example 1

[0108]

[0109] Synthesis of A2:

[0110] A1 (100g), 40% (NH 4 ) 2 Add S (2000mL) and THF (1800mL) into a 5L three-necked flask in turn, heat up to an internal temperature of 27-30°C under mechanical stirring, and keep warm for reaction (requires condensation reflux and exhaust gas absorption device), react for 4 days, and monitor the reaction by TLC ( Developing solvent: dichloromethane / methanol=10 / 1), the reaction of raw material A1 is basically complete. Separate the upper organic phase from the reaction solution, extract the lower aqueous phase with 1000mL and 500mL of ethyl acetate, combine the upper layer solution, wash with cold 0.2N NaOH 1500mL×2, and then wash with pure water 1000mL×2. Concentrate to dryness under reduced pressure at 45°C to obtain 112 g of white solid crude product, HPLC: 97.7%.

[0111] Refining: Add 112g of the crude product A2 into a 1L three-necked flask, add 330mL of methyl tert-butyl ether, stir and heat to reflux for 1h, drop to room tem...

preparation example 2

[0113] Synthesis of C1:

[0114]

[0115] Add THF 750mL, CO (66g) into a 3L three-necked flask, cool down to the internal temperature 0~-5°C under mechanical stirring, add Boc-sarcosine 89.8g, DMAP (17.4g) and DCM (750mL), the system dissolves After clearing, add 91.8 g of 1-(3-dimethylaminopropyl)-3-ethylcarbodiimide hydrochloride, keep it warm at 0~-5°C for about 20 hours, and monitor it by TLC (developer: acetone) until the reaction is complete. The reaction solution was filtered, and the filtrate was concentrated and dried under reduced pressure at 30°C to obtain an oil, which was dissolved by adding 2L of DCM, washed once with 1L of deionized water, washed with 1L×2 of 2% ammonia water, and then washed with 1L×2 of deionized water. The phase was concentrated under reduced pressure at 30°C to 35°C to obtain 193.8 g of a color-like solid.

[0116] Refining: Add 450 mL of isopropanol to 193.8 g of solids, stir and heat to reflux until dissolved, stir and crystallize at ...

Embodiment 1

[0118] Synthesis of A3:

[0119]

[0120] Add A2 (30g) into a 1L three-neck flask, add 195mL of 95% ethanol, and heat up to dissolve under magnetic stirring. The reaction was incubated at 65°C for about 15 hours, monitored by TLC (developing solvent: dichloromethane / methanol=15 / 1) until the reaction was complete. After the reaction is completed, lower the internal temperature to 40°C, add 30 mL of deionized water to the reaction solution, adjust the pH of the system to 5-6 with triethylamine, concentrate the reaction solution at 40°C-45°C, and remove the remaining concentrated water. Add 350mL of toluene and 350mL of water to the oil, stir to dissolve, separate the organic phase, and then wash with 0.2N H 2 SO 4 The aqueous solution was washed with 200mL×2, and then purified water was washed with 200mL×3, and the toluene phase was concentrated under reduced pressure at 45°C-55°C to obtain about 46g of oil (crude product A3).

[0121] Refining: Dissolve A3 oil with 90mL of ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
wavelengthaaaaaaaaaa
Login to View More

Abstract

The invention belongs to the technical field of pharmaceutical synthesis, and in particular, relates to a preparation method of isavuconazonium sulfate and an intermediate thereof. The preparation ofisavuconazonium sulfate comprises the preparation process of a compound C2 and a compound A4. Therefore, the preparation process has higher efficiency, and column chromatography purification is not needed. When the compound A4 is used for deprotection and ion exchange, a solid can be obtained only through simple purification steps, such as direct recrystallization purification, filtration and drying. Therefore, compared with the prior art, the preparation method has high purity of the products and better synthesis efficiency.

Description

technical field [0001] The invention belongs to the technical field of medicine synthesis, and in particular relates to a preparation method of isavuconazole sulfate and an intermediate thereof. Background technique [0002] On March 6, 2015, the U.S. Food and Drug Administration (FDA) approved Cresemba (isavuconazole sulfate), a new antifungal product, for the treatment of invasive aspergillosis [aspergillosis] and invasive mucormycosis [mucormycosis], a rare but serious infection. Isavuconazole is a broad-spectrum, water-soluble azole antifungal drug designated as a Qualified Infectious Disease Product (QIDP) in the United States. The drug has fast track approval for the treatment of invasive fungal infections in patients with moderate to severe renal insufficiency, and orphan drug designation for the treatment of invasive aspergillosis and zygomycosis. [0003] The preparation technology of isavuconazole sulfate ester comprises the preparation of following two key inter...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07D213/75C07D417/14
CPCC07D213/75C07D417/14
Inventor 崔东冬刘保全张玉良
Owner 重庆世森医药科技有限公司